2020

1. Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients: 12-month outcomes of a randomized study

   Acta Ophthalmologica, Vol. 98, Núm. 7, pp. e820-e829